Shasqi

Shasqi, Inc. was founded in 2018 as a privately held company. Shasqi has developed cancer treatments aimed at using bioorthogonal chemistry for localized drug delivery. Its treatments can deliver multiple drugs to tumors with fewer side effects, enabling doctors to treat patients in an enhanced manner.